Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Apr 1;153(4):1004–1008. doi: 10.1084/jem.153.4.1004

Neonatal treatment with low doses of anti-idiotypic antibody leads to the expression of a silent clone

PMCID: PMC2186123  PMID: 7019374

Abstract

BALB/c mice immunized with bacterial levan (BL) produce an immune response that fails to generate antibody expressing the idiotype (Id) of the beta (2 leads to 6) fructosan-binding myeloma protein ABPC 48 (A48). Pretreatment of newborn BALB/c mice (at 1 d of age) with 0.01-10 microgram of affinity purified BALB/c anti-A48 Id antibody followed by immunization with BL 1-2 mo later produces an anti-BL response that expresses the A48 Id. This shows that A48 Id+ anti-BL clones belong to a normally silent fraction of the anti-BL repertoire. The activation of A48 Id+ anti-BL clones anti-A48 Id antibody is specific because the pretreatment of newborn mice with anti-MOPC 384 Id antibody, followed by immunization with BL, does not lead to its activation. Moreover, pretreatment of mice with anti-A48 Id antibody does not alter the MOPC 460 Id+ component of the anti-TNP response. It is also important to note that the activation of the A48 Id+ clone in pretreated mice requires subsequent immunization with BL.

Full Text

The Full Text of this article is available as a PDF (304.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker P. J., Stashak P. W., Prescott B. Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells. Appl Microbiol. 1969 Mar;17(3):422–426. doi: 10.1128/am.17.3.422-426.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bona C. A., Heber-Katz E., Paul W. E. Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones. J Exp Med. 1981 Apr 1;153(4):951–967. doi: 10.1084/jem.153.4.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bona C., Hooghe R., Cazenave P. A., Leguérn C., Paul W. E. Cellular basis of regulation of expression of idiotype. II. Immunity to anti-MOPC-460 idiotype antibodies increases the level of anti-trinitrophenyl antibodies bearing 460 idiotypes. J Exp Med. 1979 Apr 1;149(4):815–823. doi: 10.1084/jem.149.4.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bona C., Lieberman R., Chien C. C., Mond J., House S., Green I., Paul W. E. Immune response to levan. I. Kinetics and ontogeny of anti-levan and anti-inulin antibody response and of expression of cross-reactive idiotype. J Immunol. 1978 Apr;120(4):1436–1442. [PubMed] [Google Scholar]
  5. Bona C., Mond J. J., Stein K. E., House S., Lieberman R., Paul W. E. Immune response to levan. III. The capacity to produce anti-inulin antibodies and cross-reactive idiotypes appears late in ontogeny. J Immunol. 1979 Oct;123(4):1484–1490. [PubMed] [Google Scholar]
  6. Eichmann K., Rajewsky K. Induction of T and B cell immunity by anti-idiotypic antibody. Eur J Immunol. 1975 Oct;5(10):661–666. doi: 10.1002/eji.1830051002. [DOI] [PubMed] [Google Scholar]
  7. Inman J. K. Thymus-independent antigens: the preparation of covalent, hapten-ficoll conjugates. J Immunol. 1975 Feb;114(2 Pt 1):704–709. [PubMed] [Google Scholar]
  8. Kelsoe G., Reth M., Rajewsky K. Control idiotope expression by monoclonal anti-idiotope antibodies. Immunol Rev. 1980;52:75–88. doi: 10.1111/j.1600-065x.1980.tb00331.x. [DOI] [PubMed] [Google Scholar]
  9. Leon M. A., Young N. M., McIntire K. R. Immunochemical studies of the reaction between a mouse myeloma macroglobulin and dextrans. Biochemistry. 1970 Feb 17;9(4):1023–1030. doi: 10.1021/bi00806a043. [DOI] [PubMed] [Google Scholar]
  10. Lieberman R., Bona C., Chien C. C., Stein K. E., Paul W. E. Genetic and cellular regulation of the expression of specific antibody idiotypes in the anti-polyfructosan immune response. Ann Immunol (Paris) 1979 Mar-Apr;130(2):247–262. [PubMed] [Google Scholar]
  11. Lieberman R., Potter M., Humphrey W., Jr, Mushinski E. B., Vrana M. Multiple individual and cross-specific indiotypes on 13 levan-binding myeloma proteins of BALB/c mice. J Exp Med. 1975 Jul 1;142(1):106–119. doi: 10.1084/jem.142.1.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rittenberg M. B., Pratt K. L. Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc Soc Exp Biol Med. 1969 Nov;132(2):575–581. doi: 10.3181/00379727-132-34264. [DOI] [PubMed] [Google Scholar]
  13. TSUMITA T., OHASHI M. A SYNTHETIC ACYL POLYSACCHARIDE AND THE HEMAGGLUTINATION ACTIVITY. J Exp Med. 1964 Jan 1;119:1017–1025. doi: 10.1084/jem.119.6.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Trenkner E., Riblet R. Induction of antiphosphorylcholine antibody formation by anti-idiotypic antibodies. J Exp Med. 1975 Nov 1;142(5):1121–1132. doi: 10.1084/jem.142.5.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wilder R. L., Yuen C. C., Subbarao B., Woods V. L., Alexander C. B., Mage R. G. Tritium (3H) radiolabeling of protein A and antibody to high specific activity: application to cell surface antigen radioimmunoassays. J Immunol Methods. 1979;28(3-4):255–266. doi: 10.1016/0022-1759(79)90192-3. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES